6 studies found for:    inhaled treprostinil sodium | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching
Conditions: Pulmonary Arterial Hypertension;   Chronic Obstructive Pulmonary Disease
Intervention:
2 Recruiting Beraprost-314d Added-on to Tyvaso® (BEAT)
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Beraprost Sodium 314d Modified Release Tablets;   Drug: Placebo
3 Recruiting Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: inhaled prostacyclin;   Drug: prostacyclin;   Drug: subcutaneous and intravenous prostacyclin;   Drug: oral ERA;   Drug: oral PDE5 inhibitors
4 Recruiting Treatment of Pulmonary Hypertension Associated COPD With Inhaled Treprostinil-1
Conditions: Pulmonary Hypertension;   COPD
Intervention: Drug: Inhaled Treprostinil Therapy
5 Recruiting A 48-week Study of the Effect of Dual Therapy (Inhaled Treprostinil and Tadafafil) Versus Monotherapy (Tadalafil), 2 FDA Approved Pulmonary Hypertension Medications
Condition: Hypertension, Pulmonary
Interventions: Drug: inhaled treprostinil;   Drug: tadalafil
6 Recruiting A Study of Ranolazine Acute Administration and Short Term Administration in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Ranolazine;   Drug: Placebo

Indicates status has not been verified in more than two years